Profile of Dr Darrin M Disley OBE
Darrin is a scientist, entrepreneur, angel investor and enterprise champion who has raised over $525 million business financing and closed over $600 million in commercial deals.
He is currently CEO of Mogrify Ltd, a UK biotechnology company that has developed a revolutionary direct cell conversion technology that aims to transform the development of lifesaving cell therapies.
He is also Chairman of Celixir plc a regenerative medicine company founded by Nobel Prize winner Sir Martin Evans whose lead product is HeartCel which has just begun a pivotal Phase 2B trial to treat patients undergoing coronary artery bypass graft surgery.
Prior to this he was a co-founder and CEO of Horizon Discovery Group plc a company he led for 11 years from $200 thousand seed funding to a $113 million IPO and a peak market capitalisation of $550 million and a co-founder, investor and Chairman of GeoSpock Ltd a rapidly-growing tech company with a mission to bring contextual understanding to the everything connected world.
In recent years, he has been named UK Quoted Company Entrepreneur, UK Life Science Public Company, UK Iconic Male Entrepreneur, European Life Science Business Leader and Scrip Biotech and Pharma Executive of Year as well as one of the 100 game-changing disruptive UK entrepreneurs.
Darrin supports education, entrepreneurship and mentoring programs in the UK, via the Professor Christopher R Lowe Carpe Diem Enterprise Fund, and has backed over 40 start-up life science, technology and social enterprises.
Darrin is Enterprise Fellow at the Department of Chemical Engineering and Biotechnology, University of Cambridge, Honorary Fellow of the Cambridge Judge Business School and Honorary Visiting Fellow at the School of Environmental and Life Science at the University of Salford.
He holds a BSc in Chemistry and a DSc (Honoris Causa) from the University of Salford and a PhD in Biotechnology from the University of Cambridge.
In 2016 Darrin was conferred with a lifetime-held Queens Award for Enterprise Promotion and in 2018 was made an Officer of the Order of the British Empire by Queen Elizabeth II for his services to business and enterprise in the healthcare sector.